Health Care: Drugs

Dr Reddy's Laboratories Ltd (RDY: NYSE)

$45.59 -0.51 | -1.11%
08/31/16 - 11:55 AM ET
Company Income Statement
Mar 2016 Mar 2015 Mar 2014 Mar 2013
Sales 2.33B 2.37B 2.21B 2.14B
Cost of Sales 785.79M 874.43M 823.18M 921.54M
Gross Operating Profit 1.54B 1.50B 1.39B 1.22B
Selling, General, and Administrative Expenses 688.27M 680.93M 648.06M 617.27M
Research & Development 268.58M 279.01M 207.24M 141.05M
Operating Income before D & A (EBITDA) 587.26M 535.17M 530.07M 457.11M
Depreciation & Amortization 154.37M 129.52M 118.74M 101.99M
Interest Income 21.07M 16.97M 27.97M 27.17M
Other Income - Net -36.25M 42.05M 0.00 0.00
Special Income / Charges 0.00 0.00 23.66M 32.92M
Total Income Before Interest Expenses (EBIT) 421.17M 467.79M 465.87M 417.12M
Interest Expense 12.44M 17.46M 21.29M 18.71M
Pre-Tax Income 408.73M 450.33M 444.59M 398.40M
Income Taxes 107.33M 95.68M 85.12M 90.06M
Minority Interest 0.00 0.00 0.00 -18.38K
Net Income From Continuing Operations 301.40M 354.64M 359.47M 308.34M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 301.40M 354.64M 359.47M 308.34M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 301.40M 354.64M 359.47M 308.36M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
301.40M 354.64M 335.80M 275.42M
Preferred Dividends
Net Income Available To Common 301.40M 354.64M 359.47M 308.34M
Basic EPS from Continuing Ops. 1.77 2.08 2.11 1.82
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.77 2.08 2.11 1.82
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.77 2.08 2.11 1.82
Basic Normalized Net Income/Share 1.77 2.08 1.97 1.62
EPS fr Continuing Ops. 1.76 2.07 2.11 1.81
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.76 2.07 2.11 1.81
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.76 2.07 2.11 1.81
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.76 2.07 1.97 1.62
Dividends Paid per Share 0.31 0.29 0.26 0.23

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter